Fathom Health

AI-driven healthcare revenue cycle optimization

San Francisco, California, United States

About Fathom Health

Fathom Health focuses on improving the healthcare revenue cycle by using artificial intelligence to automate administrative tasks like transcription and documentation. This automation helps healthcare providers, such as hospitals and clinics, reduce the time spent on paperwork, allowing them to concentrate more on patient care. The company operates on a business-to-business model, earning revenue through subscription fees and service contracts with its clients. What sets Fathom Health apart from its competitors is its use of AI-enabled bots, which enhance both the efficiency and accuracy of revenue cycle management. The ultimate goal of Fathom Health is to improve financial outcomes for healthcare providers by streamlining their operations.

San Francisco, CaliforniaHeadquarters
2017Year Founded
$59.2MTotal Funding
SERIES_BCompany Stage
Enterprise Software, AI & Machine Learning, HealthcareIndustries
51-200Employees

Benefits

Unlimited Paid Time Off
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Home Office Stipend
Company Social Events
Company Equity

Risks

Emerging AI healthcare startups increase competition, threatening Fathom's market share.
Potential regulatory changes in AI and data privacy could impact operations.
Economic downturns may reduce budgets, affecting revenue from subscriptions and contracts.

Differentiation

Fathom Health uses AI to automate medical coding, reducing administrative burdens.
The platform offers real-time audits, enhancing compliance and accuracy for healthcare providers.
Fathom's B2B model focuses on subscription fees and service contracts for revenue.

Upsides

AI-driven coding automation is increasingly adopted to improve accuracy and reduce burdens.
Healthcare AI market projected to grow to $45.2 billion by 2026, boosting demand.
Shift towards value-based care aligns with Fathom's efficiency-focused offerings.

Funding

Total raised$59.15 M
Latest valuation$230.00 M
StageSERIES_B